| Andersson KE, Sarawate C, Kahler KH, et al.
Cardiovascular morbidity, heart rates and use of antimuscarinics in patients with overactive bladder. [JOURNAL ARTICLE]
BJU Int 2009 Nov 17.
Abstract | Full Citation | Find Related Articles | | Tzefos M, Dolder C, Olin JL
Fesoterodine for the Treatment of Overactive Bladder (December) (CE). [JOURNAL ARTICLE]
Ann Pharmacother 2009 Nov 17.
Abstract | Full Citation | Find Related Articles | | Shamliyan TA, Wyman JF, Ping R, et al.
Male urinary incontinence: prevalence, risk factors, and preventive interventions. [Journal Article]
Rev Urol 2009; 11(3):145-65.
Abstract | Full Citation | Find Related Articles | | Malhotra BK, Crownover PH, Labadie R, et al.
The pharmacokinetic profile of fesoterodine 8 mg with daytime or nighttime dosing. [JOURNAL ARTICLE]
Eur J Clin Pharmacol 2009 Nov 14.
Abstract | Full Citation | | Macdiarmid SA, Peters KM, Shobeiri SA, et al.
Long-Term Durability of Percutaneous Tibial Nerve Stimulation for the Treatment of Overactive Bladder. [JOURNAL ARTICLE]
J Urol 2009 Nov 12.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Zimmern P, Litman HJ, Mueller E, et al.
Effect of fluid management on fluid intake and urge incontinence in a trial for overactive bladder in women. [JOURNAL ARTICLE]
BJU Int 2009 Nov 13.
Abstract | Full Citation | Find Related Articles | | Füllhase C, Soler R, Gratzke C, et al.
Urodynamic evaluation of fesoterodine metabolite, doxazosin and their combination in a rat model of partial urethral obstruction. [JOURNAL ARTICLE]
BJU Int 2009 Nov 3.
Abstract | Full Citation | | Gallagher BD, Taft BR, Lipshutz BH
Asymmetric Conjugate Reductions of Coumarins. A New Route to Tolterodine and Related Coumarin Derivatives. [JOURNAL ARTICLE]
Org Lett 2009 Oct 30.
Abstract | Full Citation | Publisher Full Text | | Chapple C
Antimuscarinics in men with lower urinary tract symptoms suggestive of bladder outlet obstruction due to benign prostatic hyperplasia. [JOURNAL ARTICLE]
Curr Opin Urol 2009 Oct 28.
Abstract | Full Citation | | Malhotra B, Gandelman K, Sachse R, et al.
The Design and Development of Fesoterodine as a Prodrug of 5-hydroxymethyl Tolterodine (5-HMT), the Active Metabolite of Tolterodine. [JOURNAL ARTICLE]
Curr Med Chem 2009 Oct 15.
Abstract | Full Citation | Find Related Articles |   |
|
| |
Advertise on this site.
|
